Back to NewsPublished: 19 Jan 2026Download AppJoin TelegramWhy Sun Pharma’s $10B Organon Bid Could Redefine US Pharma Playbook – Risks & Rewards#Sun Pharma#Organon#Pharma M&A#Biosimilars#Investing#US MarketDownload AppJoin CommunityShare Article